To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Acoustic Neuroma Association of Canada


PO Box PMB #1005
7-B Pleasant Blvd
Toronto, ON, M4T1K2 Canada



800 Number


Email Address

[email protected]


The Acoustic Neuroma Association of Canada (ANAC) is a non-profit, self-help organization dedicated to providing a comfortable environment for people who have or are facing the removal of acoustic neuromas and other tumors involving the cranial nerves. Acoustic neuromas are benign (noncancerous) tumors affecting the eighth cranial nerve, which is located in the auditory canal of the ear. Established in 1984, ANAC provides support; furnishes information on patient rehabilitation to physicians and healthcare personnel interested in the treatment of benign tumors and the alleviation of post-surgical problems; and promotes and supports research on the cause, development, and treatment of acoustic neuromas. ANAC consists of 500 members and produces educational materials including a quarterly newsletter titled, "The Connection," a pamphlet on acoustic neuroma, and a brochure titled, "The Hope is Recognition and Treatment." Program activities include regular support group meetings, patient advocacy, patient networking and patient education.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.